Well, if you read my post you would see that NWBO is doing exactly what is required to reach “large upfront cash.” To get that kind of partnership, you need to have clinical data that are validated by independent peer review ..and NWBO is accumulating more and more of those data from UCLA (beyond the P3), and Roswell data are also relevant. Additionally, NWBO is collecting valuable safety and efficacy data from compassionate use patients.
Market Data 
Markets 
AI
